NEW YORK, USA/LEIPZIG, Germany: Patients that suffer from a very rare condition affecting the oral mucosa may soon get relief from new research conducted in the US. In a recent study, scientists from the Tufts University near Boston claim to have found evidence that the so-called Chronic Ulcerative Stomatitis (CUS), characterised by recurring painful ulcers, is mainly caused by an autoimmune response of the body that destroys the binding of cells inside the surface tissue layer of the mouth.
According to the scientist, only a dozen cases of CUS have been reported worldwide since the condition was first clinically identified in 1989 but more patients could be affected due to the extensive testing procedure and low awareness among dental clinicians. They said although prior it was known that affected patients had specific autoantibodies, researchers were not able to determine how much these actually contributed to the condition. With help of the new findings, CUS could now be classified as an autoimmune disease in order to allow better management of the symptoms.
Due to its unique resistance to standard medication like corticosteroids, successful treatment of CUS has been achieved only in some cases through hydroxychloroquine, a prescription drug primarely used to prevent malaria as well as to treat rheumatoid arthritis or lupus. By better understanding the mechanisms linking the autoimmune response to ulcerative sores, new treatment approaches could be developed to manage the condition, the scientists said.
So far, CUS has been found primarily in middle-aged Caucasian woman. It can only be diagnosed by surgical biopsy using immunofluorescence microscopic examination in an outside lab. In normal clinical settings it can be taken for oral erosive lichen planus, another more common chronic condition affecting mucosal surfaces and also considered to be an autoimmune disease.
Taking place from 24 to 26 February, this year’s Chicago Dental Society Midwinter Meeting is returning to an in-person format with gusto. More than 250 ...
LOUISVILLE, Ky., USA: A University of Louisville scientist has found a way to prevent inflammation and bone loss surrounding the teeth by blocking a natural...
NEW YORK, USA/LEIPZIG, Germany: Osseointegration remains one of the biggest challenges in implant dentistry. Scientists from the North Carolina ...
STONY BROOK, N.Y., US: The applicability and efficacy of artificial intelligence (AI) within dentistry appears to be limitless. With each passing day, ...
BOSTON, Mass., USA: Researchers from the Harvard School of Medicine have discovered that a chemical compound found in a traditional Chinese root extract ...
PITTSBURGH & ANN HARBOR, Mich./CAMBRIDGE, Mass., USA: Enamel is known to be one of the hardest tissues in the human body. Researchers from the Forsyth ...
Like in every year, in 2021, the Chicago Dental Society (CDS) Midwinter Meeting, one of the largest dental exhibitions in North America, will welcome ...
More than three decades have passed since the emergence of human immunodeficiency virus (HIV) as a global pandemic. More than any other infection, it is ...
March 20 marks World Oral Health Day, an important global event aimed at raising awareness about the importance of oral health and its impact on overall ...
MORGANVILLE, N.J., USA: November is American Diabetes Month, and the New Jersey Society of Periodontists (NJSP) would like patients and caregivers alike to ...
Live webinar
Thu. 11 September 2025
1:00 PM EST (New York)
Live webinar
Mon. 15 September 2025
1:00 PM EST (New York)
Prof. Dr. med. dent. Stefan Wolfart
Live webinar
Tue. 16 September 2025
11:00 AM EST (New York)
Prof. Dr. Dr. Florian Guy Draenert
Live webinar
Tue. 16 September 2025
12:30 PM EST (New York)
Dr. Kay Vietor, Birgit Sayn
Live webinar
Tue. 16 September 2025
1:00 PM EST (New York)
Dr. Paweł Aleksandrowicz PhD
Live webinar
Tue. 16 September 2025
8:00 PM EST (New York)
Live webinar
Wed. 17 September 2025
6:30 AM EST (New York)
To post a reply please login or register